13F Notebook
← Dashboard
Fund detail

Parnassus Investments

large-active, lo, esg

Quarters 53
2026-06-30 $37.45B
Positions 135
Showing 11 of 11 rows (filtered from 146)

Price is the latest implied close from the selected quarter's 13F (value ÷ shares). Est. Cost is a running average that assumes each quarter's trades cleared near the midpoint of consecutive 13F closes (or yfinance VWAP when available). Most accurate for slow accumulators, least accurate for activists who build positions in a few days. PUT/CALL rows are option exposure and are marked separately.

# Issuer Value ↓ Weight Shares Share Δ Share Δ % Prev Weight First Held Price Est. Cost Unrealized % Status
1 ALNYLAM PHARMACEUTICALS INC $0 0 -48,991 -100.00% 0.05%
2 BILL HOLDINGS INC $0 0 -1,662,250 -100.00% 0.19%
3 BIO RAD LABS INC $0 0 -254,305 -100.00% 0.21%
4 BROADRIDGE FINL SOLUTIONS IN $0 0 -258,836 -100.00% 0.12%
5 BROWN & BROWN INC $0 0 -64,113 -100.00% 0.01%
6 INSMED INC $0 0 -69,515 -100.00% 0.03%
7 METTLER TOLEDO INTERNATIONAL $0 0 -13,864 -100.00% 0.05%
8 PROCORE TECHNOLOGIES INC $0 0 -282,928 -100.00% 0.05%
9 SALESFORCE INC $0 0 -1,949,698 -100.00% 1.07%
10 TRANSUNION $0 0 -890,979 -100.00% 0.18%
11 VERISK ANALYTICS INC $0 0 -1,760,761 -100.00% 0.98%